Intertek, a leading Total Quality Assurance provider to industries worldwide, will be exhibiting at Booth #613 at DIA's (Drug and Information Association) 53rd Annual Meeting taking place in Chicago, Illinois, from June 18th-22nd, 2017.
DIA 2017 is a highly anticipated event as it is the largest, longest-run meeting in the life sciences industry. This year's theme will focus on 'Driving Insights to Action' and attendees will benefit from global insights to improve health through the development of technologies and lifesaving medicines. DIA 2017 will attract more than 7,000 global health care professionals in the pharmaceuticals, biotechnology, and medical device industries from more than 51 countries worldwide. Attendees are able to choose form over 160 sessions and meet with more than 450 exhibiting companies.
DIA 2017 is the Ideal platform for stakeholders wishing to gain additional knowledge in the field of new therapies and contribute to discussions on health and well-being. This must-attend event will provide participants an opportunity to exchange knowledgeable information and insights beyond boundaries to advance innovation in health care product development and life cycle management globally.
Intertek Health, Environmental & Regulatory Services (HERS), along with our laboratory services teams can help guide clients through the complex hurdles for pharmaceutical and healthcare product development and regulatory requirements. For example, understanding the challenges related to product classification can be very complex as the legal framework varies across different regions which impacts the classification of a product. Intertek's regulatory experts can assist clients with product classification, based on product design, formulations, intended claims, etc. Additionally, they can help clients meet the regulatory requirements in each desired country for marketing. To set-up a meeting during the show, please contact pharma.sci-reg@intertek.com or visit us at Booth #613.
To learn more about the regulatory and scientific consultancy services offered by our experts and within the larger Intertek organization visit: http://www.intertek.com/pharmaceutical/
About Intertek
Total Quality. Assured.
Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 42,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers' operations and supply chains. Intertek Total Quality Assurance expertise, delivered consistently with precision, pace and passion, enabling our customers to power ahead safely.
Intertek Group plc published this content on 14 June 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 14 June 2017 20:09:14 UTC.
Original documenthttp://www.intertek.com/events/2017/06-14-intertek-to-exhibit-at-dia-2017/
Public permalinkhttp://www.publicnow.com/view/7918A48DFAF603DD1CD154917328E950308A5DBF
Intertek Group plc is one of the world's leading groups specializing in analysis, control and certification of products and systems. Net sales break down by activity as follows:
- control and certification services for consumer goods (63.4%): including food, pharmaceuticals, textiles, beauty products, consumer electronics, toys, shoes, home appliances, cars. Also, the group is developing an activity to monitor the certification of international standards;
- monitoring and assessment of petroleum and agricultural products (19.9%). Besides, Intertek Group plc offers inspection services to government system and regulators to support commercial activities, contributing to the movement of goods across borders;
- development of quality assurance solutions (16.7%): for the supply chain of oil, gas, nuclear and mining industries.
At the end of 2022, the group operated more than 1,000 inspection offices and laboratories in the world.
Net sales are distributed geographically as follows: the United Kingdom (6.4%), the United States (30%), China and Hong Kong (18.5%), Australia (5.5) and other (39.6%).